CSF2 and neuroblastoma: Once established that these therapeutic combinations were feasible and tolerated, the efficacy of immunotherapy (ch14.18, GM-CSF, IL-2, and isotretinoin) was compared to that of standard therapy (isotretinoin alone) in a cohort of NB patients who had a response to induction therapy and hematopoietic stem cell transplantation.